| Turquia | Austria | Spanyol | |
| Terapi target | dari $1,000 | dari $12,000 | dari $15,000 |
| Terapi Lutetium-177 | dari $8,800 | dari $35,000 | dari $12,000 |
| Terapi Aktinium-225 | dari $22,955 | dari $55,000 | dari $45,000 |
| Onkoterapi | dari $450 | - | - |
Bookimed tidak menambah biaya tambahan dalam harga Terapi target. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik untuk Terapi target Anda saat tiba.
Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam Terapi target dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.
Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan Terapi target Anda.
Berspesialisasi dalam terapi target dan imunoterapi kanker – Dr. Karagöz membawa pengalaman onkologi lebih dari 20 tahun ke Anadolu Medical Center.
Dr. Eda Tanrikulu berspesialisasi dalam onkologi medis dan kemoterapi di Anadolu Medical Center – meraih peringkat ke-3 dalam ujian onkologi medis Turki.
Dr. Solak berspesialisasi dalam terapi target untuk berbagai jenis kanker, menempuh pendidikan di Hacettepe University Cancer Institute dan MD Anderson Cancer Center.
Dr. Sinan Karaaslan — Dokter Onkologi Medis di Anadolu Medical Center (sejak 2014). Ia menangani kanker payudara, kolorektal, dan genitourinari; dalam onkologi medis sejak 2003. Anggota dari Asosiasi Medis Turki, Masyarakat Onkologi Medis Turki, dan Masyarakat Kanker Paru-Paru Turki.
Mengapa pasien memilih dan mempercayai Dr. Karaaslan:
Targeted therapy is precision medicine that uses drugs to attack specific genetic mutations or proteins driving cancer growth. Unlike chemotherapy, which kills all rapidly dividing cells, this approach spares healthy tissue, reduces systemic side effects like hair loss, and requires specialized genomic testing before treatment begins.
Bookimed Expert Insight: Turkish oncology centers like Anadolu Medical Center often combine targeted therapy with immunotherapy protocols. This dual approach is facilitated by their direct collaboration with Johns Hopkins Medicine. By using genomic sequencing first, surgeons can select precise drugs like Lutetium-177, which may cost $8,800 in Turkey compared to nearly $40,000 elsewhere.
Patient Consensus: Many patients find they can continue working remotely during treatment since it avoids the severe neutropenia of chemo. Everyone emphasizes confirming that the specific mutation-targeted drug is in stock before flying to Istanbul.
Targeted therapy in Turkey primarily treats lung, breast, and colorectal cancers by identifying specific genetic mutations. Medical oncologists frequently prescribe HER2 inhibitors for breast cancer and EGFR or ALK inhibitors for non-small cell lung cancer. Specialized centers in Istanbul also prioritize melanoma, kidney, and gastrointestinal stromal tumors.
Bookimed Expert Insight: Turkish oncology centers often follow U.S. protocols due to high-level affiliations, such as Anadolu Medical Center’s partnership with Johns Hopkins Medicine. These clinics provide EGFR and ALK inhibitors at significantly lower costs than the US, where similar treatments average $40,000. Patients can save up to 93% while receiving care from professors with over 20 years of experience who have trained at global institutions like MD Anderson or Rambam.
Patient Consensus: Patients emphasize the importance of completing comprehensive NGS mutation testing before traveling. Many choose Turkey for the speed of starting targeted drug protocols once a genetic match is confirmed.
Leading Turkish oncology centers maintain elite international accreditations, ranking Turkey among the top five countries globally for facilities holding Joint Commission International (JCI) certification. These standards ensure over 1,200 quality measures are met, matching protocols used at top-tier medical institutions like the Mayo Clinic.
Bookimed Expert Insight: Anadolu Medical Center stands out because it holds both the OECI and IASIOS certificates specifically for interventional oncology. While many Turkish hospitals have JCI, finding one with these cancer-specific European credentials usually signals a more specialized multidisciplinary tumor board approach.
Patient Consensus: Patients emphasize verifying that a specific hospital's oncology department is JCI-certified on the official registry before booking. They also recommend bringing records translated into English to ensure smooth processing within these accredited systems.
Clinicians use high-throughput diagnostic tools like next-generation sequencing, liquid biopsies, and molecular profiling to personalize targeted therapy. These advanced technologies identify specific genetic mutations, such as EGFR or ALK, allowing surgeons to select medications that precisely attack cancer cells while sparing healthy tissue.
Bookimed Expert Insight: Turkish oncology centers like Anadolu Medical Center maintain a strategic partnership with Johns Hopkins Medicine. This collaboration allows patients to receive treatment based on specific U.S. clinical protocols. Our data shows that top-tier facilities combine these international standards with AI-supported 3 Tesla MRI and digital PET/CT to refine diagnostic accuracy.
Patient Consensus: Patients emphasize the importance of liquid biopsies to track how tumors evolve over time. Many recommend verifying that clinics use CAP-certified labs for genetic profiling to ensure the most accurate results for rare mutations.
Turkey offers a comprehensive spectrum of targeted therapies including monoclonal antibodies, small molecule inhibitors, and tyrosine kinase inhibitors (TKIs). Specialized oncology centers in Istanbul focus on precision medicine, utilizing genetic profiling to match patients with FDA-approved drugs for breast, lung, and colorectal cancers.
Bookimed Expert Insight: While many clinics offer targeted drugs, the highest success rates are found at centers with integrated NGS labs. Anadolu Medical Center and Memorial Sisli utilize in-house molecular testing to identify specific mutations. This eliminates the 2-week wait typical for external lab results, allowing treatment to begin faster.
Patient Consensus: Patients emphasize the importance of bringing original pathology slides from home. Having these reviewed by Turkish experts ensures the targeted drug matches the tumor’s specific genetic profile without repeating invasive biopsies.
Turkish hospitals provide comprehensive support for international patients through dedicated departments that manage logistics, translation, and medical coordination. Major facilities like Anadolu Medical Center and Memorial Health Group offer all-inclusive services covering airport transfers, local hotel bookings, and 24/7 interpreter support in over 20 languages.
Bookimed Expert Insight: Quality signals for international care are strongest at Anadolu Medical Center due to its Johns Hopkins Medicine affiliation. This partnership ensures all diagnostic and treatment protocols for targeted therapy align with U.S. standards while maintaining Turkey’s significantly lower costs.
Patient Consensus: Patients value the seamless experience provided by personal coordinators who handle everything from local SIM cards to post-treatment hotel stays. Many recommend confirming your specific coordinator's availability before arrival to ensure smooth communication during consultations.